Grimalt, B. F., Brasó-Maristany, F., Petit, A., Raúl, O., Gómez, N., Vicente, M., Falo, C., Vazquez, S., Stradella, A., Villanueva-Vázquez, R., Pla, M. J., Cordero, D., Monso, T. S., Cobo, S., Paré, L., Galván, P., Perou, C., Villagrasa, P., Prat, A., Pernas, S. (2025). HER2DX genomic test in HER2-positive breast cancer treated with 15 weeks of neoadjuvant paclitaxel, trastuzumab, and pertuzumab (THP): Final analysis from the BiOnHER clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.607